Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps ...

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

If left untreated, human immunodeficiency virus (HIV) almost always will progress to AIDS, even after many years. The immune defenses become compromised and the body is less able to defend itself ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...

If you're worried about HIV infection, you may wonder whether it's safe to have oral sex. While it's not risk-free, the chances of spreading the virus that causes AIDS are very low if you take the ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...

Many of the fears have been fueled by media reports which either overstate the risk of acquiring HIV through accidental occupational needlestick injuries or spotlight cases in which victims are ...

Charlie Sheen's contribution to HIV awareness doesn't condone the actor from allegations of concealing the disease from his ...

HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...

If you are a supplier, or another partner you can contact our legacy email address as aidsmap@outlook.com with any queries. We extend our heartfelt thanks to everyone who supported our vision for a ...

NPR Ethel Weld, an assistant professor of medicine at the Johns Hopkins University School of Medicine, describes the results from the PURPOSE 1 and PURPOSE 2 trials as "a thrilling game changer for ...